Andrew Stadnyk received his BSc Honors from the University of Manitoba and PhD from McMaster University. He received his Postdoctoral Training from the Seattle Biomedical Research Institute then. He is currently a Professor in the Science department at Dalhousie University. Prof. Dr. Stadnyk's interests include mucosal inflammatory diseases, particularly of the digestive system. In the past few years, his work has focused on the complement system and colitis, specifically how complement affects the interactions between epithelial cells and the microbes colonizing the intestines. More recently, Prof. Dr. Stadnyk has added research into understanding the inflammation behind chemotherapy-induced mucositis to mitigate this painful, debilitating side effect of cancer treatments. His research topics mainly include mucosal immunology, inflammation, colon cancer biology, cytokines, epithelial cells, colitis, anaphylatoxin, microbiome, and mucositis. In 2010, Prof. Dr. Stadnyk received a Research Leadership Award from the Crohn’s and Colitis Foundation of Canada. He received the IWK Research Award from the IWK Health Centre Board of Directors in 2013. Prof. Dr. Stadnyk was recognized in 2014 as a finalist in Halifax's Discovery Centre "Science Champion" competition.